Adrenomyeloneuropathy – a case report
DOI:
https://doi.org/10.15584/ejcem.2019.3.13Keywords:
adrenoleukodystrophy, fatty acids, steroid therapyAbstract
Introduction. Adrenoleukodystrophy is a genetic disorder linked to the X chromosome, in which the peroxisomal beta-oxidation process is disturbed. It is a metabolic disease that results in the accumulation of very long chain fatty acids (VLCFAs - very long chain fatty acids) responsible for the symptoms of damage to the adrenal cortex, gonads and the brain.
Aim. A clinical case is reported.
Description of case. This article describes the case of a 64-year-old woman who had neurological symptoms for many years, gradually increasing without significant improvement after the treatment (periodic steroid therapy).
Conclusion. Based on tests (including the determination of the ABCD1 gene and very long chain fatty acids - VLCFA), adrenoleukodystrophy was suspected.
Downloads
References
Moser HW, Raymond GV, Dubey P. Adrenoleukodystrophy: new approaches to a neurodegenerative disease. JAMA. 2005;294(24):3131-3134.
Moser HW. Adrenoleukodystrophy: phnotype, genetics, pathogenesis and therapy. Brain. 1997;120(8):1485-1508.
Siemerling E, Creutzfeld HG. Bronzekrankheit und sklerosierende Encephalomyelitis. Arch. Psych. Nervkrankh. 1923;68(1),1923:217–244.
Budka H, Sluga E, Heiss WD. Spastic paraplegia associated with Addison`s disease: variant of adrenoleukodystrophy. J. Neurol. 1976;213(3):237-250.
Griffin JW, Goren E, Schaumburg HH, Engel WK, Loriaux L. Adrenomyeloneuropathy: a probable variant of adrenoleukodystrophy. Clinical and endocrinologic aspect. Neurology. 1977;27(12):1107-1113.
Allgrove J, Clayden GS, Grant DB, Macaulay JC. Familial glucocorticoid deficiency with achalasia of the cardias and deficient tear production. Lancet. 1978; 1(8077):1284-1286.
Heffungs W, Hameister H, Ropers HH. Addison disease and cerebral sclerosis in an apparently heterozygous girl: evidence for inactivation of the adrenoleukodystrophy locus. Clin. Genet. 1980;18:184-188.
Igarashi M, Schaumburg HH, Powers J, Kihsimoto Y, Kolodny EH, Suzuki K. Fatty acid abnormality in adrenoleukodystrophy. J. Neurochem. 1976;26:851-860.
Engelen M, Kemp S, de Visser M, van Geel BM, Wanders RJA, Aubourg P, Poll BT. The X- linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow- up and management. Orphanet J Rare Dis. 2012,7:51.
Morski J. Adrenoleukodystrofia sprzężona z chromosomem X. Objawy, diagnostyka i leczenie oraz opis przypadku. Neur. Dziecięca. 2012;43.
Paláu-Hernández S, Rodriguez-Leyva I, Shiguetomi-Medina JM. Late onset adrenoleukodystrophy: A review related clinical case report. eNeurologicalSci. 2019;14:62-67.
Crane DI. Revisiting the neuropathogenesis of Zellweger syndrome. Neurochem Int. 2014;69:1-8.
Engelen M, Barbier M Dijkstra IM. X-linked adrenoleukodystrophy in women: a cross-sectional cohort study. Brain. 2014;137:693-706.
Engelen M, Kemp S, Poll BT. X-linked adrenoleukodystrophy: pathogenesis and treatment. Curr Neurol Neurosci Rep. 2014;14:486-489.
Menon GK, Orso E, Aslanidis C. Ultrastructure of skin from Refsum disease with emphasis on epidermal lamellar bodies and stratum corneum barrier lipid organization. Arch Dermatol Res. 2014;306:731-737.
Turk BR, Moser AB, Fatemi A. Therapeutic strategies in adrenoleukodystrophy. Wien Med Wochenschr. 2017;167(9-10):219-226.
Theda C, Gibbons K, Defor TE. Newborn screening for X-linked adrenoleukodystrophy: further evidence high throughput screening is feasible. Mol Genet Metab. 2014;111:55-57.
van Geel BM, Poll-The BT, Verrips A. Hematopoietic cell transplantation does not prevent myelopathy in X-linked adrenoleukodystrophy: a retrospective study. J Inherit Metab Dis. 2015;38(2):359-361.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2019 European Journal of Clinical and Experimental Medicine
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.
All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.
